(Q42248654)

19 October 2017

Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia (English)

1 reference

19 October 2017

1 reference

1 reference

Blacklock H

1

1 reference

19 October 2017

Ball L

2

1 reference

19 October 2017

Knight C

3

1 reference

19 October 2017

Schey S

4

1 reference

19 October 2017

Prentice G

5

1 reference

19 October 2017

language of work or name

1 reference

1 September 1983

1 reference

19 October 2017

Cancer Treatment Reviews

1 reference

19 October 2017

10 Suppl A

1 reference

19 October 2017

45-52

1 reference

Delayed cystitis due to cyclophosphamide

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Cyclophosphamide and hemorrhagic cystitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Methicillin hemorrhagic cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Cyclophosphamide cystitis—Identification of acrolein as the causative agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Adriamycin enhancement of cyclophosphamide-induced bladder injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Haemorrhagic radiation cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Acute hemorrhagic cystitis of childhood and papovavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Epidemics of haemorrhagic cystitis due to influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Effect of n-acetylcysteine on some aspects of cyclophosphamide-induced toxicity and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Busulfan-induced hemorrhagic cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

A review of adenoviruses in the etiology of acute hemorrhagic cystitis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Therapeutic selectivity of and predication of response to 2'-deoxycoformycin in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Hemorrhagic cystitis and vesicoureteral reflux secondary to cytotoxic therapy for childhood malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Fungal cystitis: awareness, diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Difference in bioactivity between two preparations of cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2883%2980006-1

7 January 2021

10.1016/S0305-7372(83)80006-1

Identifiers

DOI

1 reference

release_y4ywhgmnz5edzjhu6hp62ycs6e

19 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y4ywhgmnz5edzjhu6hp62ycs6e

24 November 2022

mapped directly with Wikidata item

1 reference